In the trial progresses, each patient received saw four-in-one ' quadpill ' blood pressure dropped at a healthy level in a month.
And because each drug is included in much lower doses than conventional tablets, experts believe that the combined medicine will minimize the side effects.
A small pilot trial results, published in the Lancet medical journal last night, could offer a new approach to the hundreds of thousands of people in the United Kingdom take the pills daily for blood pressure.
High blood pressure or hypertension affects more than British 17million, or adult in three.
The condition greatly increases the risk of heart attack, stroke and vascular dementia, but because it has no symptoms until it is too late often, only half of the people know that they are at risk.
Of those who have been diagnosed, hundreds of thousands taking the pill daily to control blood pressure. But they usually have a single drug--and only about half of patients saw their blood pressure drops to a healthy level.
The new study is a success rate of 100 percent. However, researchers from the Institute at the University of Sydney
George highlighting that only 18 patients participating in the trial. Further research is needed to see if the results can be repeated, they said, but preliminary findings are very interesting.
Author Research Professor Clara Chow says: ' most people receive medication with a dose of normal blood pressure control but only about half the time. In this test a small, control of blood pressure is attained for all. The trials will test now if it can be repeated and ongoing long term. '
An important step in the decline of the disease
This research involves giving patients a single dose capsules containing a quarter of each of four common drugs for blood pressure-irbesartan, hydrochlorothiazide, amlodipine and atenolol.
Researchers believe that a reduction in the dose of the drug reduced the risk of any side effects, which can include swelling in the ankle and kidney abnormalities.
Although the each lower dose of the drug, a combination of increasing their impact.
Professor Chow says: "minimizing the side effects is important for long term care, we see no problem in this essay, as you would expect with a very low dose of therapy, but this is an area where more long-term research is required.
"This could be a very important step to help reduce the burden of disease around the world." Professor Metin Avkiran, associate medical director of the heart Foundation United Kingdom, says: ' high blood pressure is a risk factor for stroke and heart attack.
' Despite encouraging results and can lead to effective treatment without the side effects ... more research is needed to ensure the security of the quad pill, long term effects on blood pressure and, in the end, if it reduces the risk of someone having an accident, stroke or heart attack before it should be considered in the clinic.
' Because the majority of people with high blood pressure have no symptoms, the majority of the battle is to identify who owns it. If you are interested, please talk to your family doctor. "
0 comments: